发明授权
![Pyrazolo[3,4-b]pyridin-6-ones as GSK-3 inhibitors](/docs/US/2007-11-27/US07300944B2/abs.jpg.600x600.jpg)
- 专利标题： Pyrazolo[3,4-b]pyridin-6-ones as GSK-3 inhibitors
- 专利标题（中）： 吡唑并[3,4-b]吡啶-6-酮作为GSK-3抑制剂
-
申请号： US10875009申请日： 2004-06-23
-
公开(公告)号： US07300944B2公开(公告)日： 2007-11-27
- 发明人: Daniel W. Kung , Travis T. Wager
- 申请人： Daniel W. Kung , Travis T. Wager
- 申请人地址： US NY New York
- 专利权人： Pfizer Inc.
- 当前专利权人： Pfizer Inc.
- 当前专利权人地址： US NY New York
- 代理商 Ye Hua; Stephen D. Prodnuk; Bryan C. Zielinski
- 主分类号： C07D471/02
- IPC分类号： C07D471/02 ; A61K31/4745
![Pyrazolo[3,4-b]pyridin-6-ones as GSK-3 inhibitors](/abs-image/US/2007/11/27/US07300944B2/abs.jpg.150x150.jpg)
摘要：
The present invention provides compounds of formula (I) the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein R1, R2 and R3 are as defined herein; pharmaceutical formulations thereof; and use thereof in the treatment of, inter alia, conditions, diseases, and symptoms such as bipolar disorder, diabetes, dementia, Alzheimer's Disease, stroke, schizophrenia, depression, hair loss, and cancer.
公开/授权文献
- US20040266815A1 Pyrazolo[3,4-b]pyridin-6-ones as GSK-3 inhibitors 公开/授权日：2004-12-30
信息查询
